5-158713074-G-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_024007.5(EBF1):c.1265C>A(p.Pro422Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000419 in 1,598,904 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P422L) has been classified as Uncertain significance.
Frequency
Consequence
NM_024007.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000330 AC: 8AN: 242124Hom.: 0 AF XY: 0.0000382 AC XY: 5AN XY: 130994
GnomAD4 exome AF: 0.0000249 AC: 36AN: 1446734Hom.: 1 Cov.: 30 AF XY: 0.0000306 AC XY: 22AN XY: 719226
GnomAD4 genome AF: 0.000204 AC: 31AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1265C>A (p.P422Q) alteration is located in exon 13 (coding exon 13) of the EBF1 gene. This alteration results from a C to A substitution at nucleotide position 1265, causing the proline (P) at amino acid position 422 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at